Abstract:Abstract Proliferating cell nuclear antigen (PCNA), also called cyclin, is an intranuclear polypeptide whose synthesis reaches its maximum during the S-phase of the cell cycle. PCNA is expressed in several kinds of proliferating cells, one of which is the mitogen-stimulated human peripheral blood lymphocyte. PCNA expression increases from the late G1 phase through the S-phase of the cell cycle. This study is focused on the regulation of PCNA expression during the G1 phase of human T lymphocytes and on the relationship between PCNA expression and the rate of T cell proliferation. Special use is made of human autoantibodies to PCNA and the development of flow cytometry to label this intranuclear polypeptide. Unstimulated purified human peripheral blood T cells were PCNA negative. T cells treated with monoclonal antibody (64.1) to the CD3 complex expressed receptors for IL 2 but did not express PCNA until exogenous IL 2 was added to the culture. PCNA expression as well as the entry of the cells into S-phase could be inhibited by IL 2 receptor antibodies. Transferrin receptors were expressed only in T cells that were stimulated with both 64.1 and exogenous IL 2. Transferrin receptors were detectable before the cells expressed PCNA. Thus, the onset of PCNA expression is a phase in cell proliferation that follows transferrin receptor expression but preceded DNA synthesis. Drugs like dexamethasone and cyclosporin, which affect the early part of G1, inhibited PCNA expression; whereas cytarabine (ara-C) and hydroxyurea, which affect the S-phase and prevent DNA synthesis, did not block PCNA expression. There was a close correlation between the number of PCNA-positive cells and the number of S-phase cells in unperturbed T cell cultures. The highest level of PCNA expression was seen in cells that were in the first cycle after stimulation. The results show that PCNA expression is regulated by a signal after IL 2 binding and that PCNA labeling is a precise indicator for human T cells that are committed to DNA synthesis. Comparing these results with previous observations on the expression of some other activation-associated antigens, we suggest that the onset of PCNA expression represents a discrete step in T cell activation.

Active Cis-Elements of PCNA Promoter in HeLa, HepG2, L-02 and MCF-7 Cell Lines.

Construction and Functional Analysis of Luciferase Reporter Plasmid Containing PCNA Gene Promoter

Response of Human DNA Polymerase Ι Promoter to N-methyl-N′-nitro-N-nitrosoguanidine

Engineering of <i>Bacillus</i> Promoters Based on Interacting Motifs between UP Elements and RNA Polymerase (RNAP) -Subunit

Polymorphic mutations in the polb gene promoter and their impact on transcriptional activity

A Point Mutation in the DNA-binding Domain of HPV-2 E2 Protein Increases Its DNA-binding Capacity and Reverses Its Transcriptional Regulatory Activity on the Viral Early Promoter.

Proliferating cell nuclear antigen (PCNA)/cyclin in activated human T lymphocytes.

Expression of proliferating cell nuclear antigen (PCNA)/cyclin during the cell cycle

The use of a human papillomavirus 18 promoter for tissue-specific expression in cervical carcinoma cells

PCNA: a silent housekeeper or a potential therapeutic target?

Hpv-2 Isolates from Patients with Huge Verrucae Vulgaris Possess Stronger Promoter Activities

Cancer Specificity of Promoters of the Genes Controlling Cell Proliferation

Proliferating cell nuclear antigen (PCNA): ringmaster of the genome

Study on the Effect of Human CMV Early Transcriptional Enhancer on Human CEA Promoter

Proliferating cell nuclear antigen (PCNA): a dancer with many partners

Revealing the essentiality of multiple archaeal pcna genes using a mutant propagation assay based on an improved knockout method.

Comparison of the transcriptional activity of hTERT, CEA and CMV promoter in human colon carcinoma cell lines

PCNA: structure, functions and interactions

Optimization of Reporter Gene Assay: Several Factors Influencing Detection of Promoter Activity.

Proliferating cell nuclear antigen (PCNA): a key factor in DNA replication and cell cycle regulation

PCNA on the crossroad of cancer